Anavex Life Sciences Corp.AVXLNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank67
3Y CAGR-10.1%
5Y CAGR-0.7%
Year-over-Year Change
Research and development spending
3Y CAGR
-10.1%/yr
vs +18.4%/yr prior
5Y CAGR
-0.7%/yr
Recent deceleration
Acceleration
-28.4pp
Decelerating
Percentile
P67
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $31.80M | -15.4% |
| 2025 | $37.59M | -10.1% |
| 2024 | $41.84M | -4.3% |
| 2023 | $43.72M | +15.3% |
| 2022 | $37.92M | +15.0% |
| 2021 | $32.98M | +30.7% |
| 2020 | $25.23M | +13.3% |
| 2019 | $22.26M | +66.8% |
| 2018 | $13.34M | +25.0% |
| 2017 | $10.67M | - |